HOW TO PREPARE A GOOD ACCEPTED
|
|
- Angelina Newton
- 5 years ago
- Views:
Transcription
1 HOW TO PREPARE A GOOD ABSTRACT AND GET IT ACCEPTED
2 This is an interactive session; be free to interrupt and ask questions at any time during the talk!
3 Some useful points when deciding if and where to submit an abstract Choose the meeting: only the best material gets into AATS, STS or EACTS conference. Prospective studies, especially when randomized, have by far the best chance. Retrospective studies carry less weight, especially when analysed over a longer time period (methods change). Institutional experience (unless it involves thousands of cases) should go to local meetings. New techniques and devices are always welcome, but beware of becoming an industry spokesman.
4 Start your work by carefully reading instructions for abstract submission
5 EACTS instructions for abstract submission
6 Automatic rejection! Institution identified, violation of rules.
7 EACTS RULES: If your work has already been presented elsewhere, it will be automatically dismissed by program committee. If it gets erroneously accepted, you will be barred from program for 2 years ( blacklisted ).
8 Read instructions carefully, and re-read your text before hitting submit button: EACTS does not correct your spelling and writing mistakes!
9 From a recent EACTS abstract 212 selected patients t included d to the study with retrospective ti data scan on postoperative bleeding after elective CABG with cardiopulmonary bypass (CPB). Study derived from two different centers: Group A patients (n=107) from our center at an altitude of 1985 meters and Group B patients (n=105) from a center in approximately sea level with 150 meters altitude. Be precise in your statements! This author s approximately sea level corresponds elsewhere to the highest peak in Denmark. Abstract was rejected!
10 EACTS Instructions for reviewers (as a rule, 5 or more for each abstract) Maximum score can be 10 (never reached); abstracts with Maximum score can be 10 (never reached); abstracts with score 1-3 are rejected, 4-5 might get in, 6 9 always get in.
11 Abstract selection for EACTS meetings Each abstract category has 5 8 experts. Grading is always anonymous! First round of abstract grading results in pre-selection of good, possible, and useless abstracts. Second round of grading (app % of remaining abstracts) is done by the program committee, first electronically, and finally during a face-face meeting of the committee. During this meeting, anonymity is usually broken to simplify the selection ( Didn t I hear this talk before? ) Finally, program committee makes detailed program, with placing abstracts in sessions, and selecting chairmen and invited discussants.
12 One of the most common errors in abstracts: False labeling of groups Give your groups self-explanatory, materialrelated labels: control and intervention ; treatment and placebo ; OPCAB and On- Pump; etc. Avoid labels like A, B and C; or Group I and Group II. Reader has to refer back to Methods to find the meaning of these labels, and your message is difficult to comprehend.
13 When analyzing an abstract, watch for following quality features Check if it is a consecutive series. Look for exclusion criteria (missing groups, elimination of high risk subsets). Data must be complete, including operative mortality. Observe the follow-up: methods, completeness (95% minimum) and length Look for conflict of interest.
14 Some examples: good, mediocre, and hopeless ones
15 Format of this session: 1. An abstract (or parts thereof) will be shown. 2. You will vote to accept, reject or leave abstract as possible 3. Vote of the program committee will be shown, with some comments.
16
17 Vote about this abstract: Press 1: Accept Press 2 Reject Press 3 Possible
18 Typical paper for a local meeting. Mortality is atrocious. What is new here, what can be learned from this material? Rejected.
19
20 Vote about this abstract: Press 1: Accept Press 2 Reject Press 3 Possible
21 No mention of selection criteria for LAD revascularization; obviously the two groups are not comparable, and other factors than additional CABG might have played a role in survival differences. Surprise: Accepted (??)
22
23 Vote about this abstract: Press 1: Accept Press 2 Reject Press 3 Possible
24 How were these particular 100 patients selected? Seems that 100% of CABG patients have depression, and 84% must be treated. Is this possible??? Conclusions are not supported by results. Rejection.
25 When planning an abstract submission to a major meeting, avoid : Small series of few patients, even in rare conditions: any achieved results can be due to chance. Reports about standard procedures, or about institutional experience. Reviewers asks: what is new? Large series of standard d procedures: everything is known about mortality in CABG, AVR or MVR, or Fallot. Presenting some extraordinary results from an unknown institution: e.g. 0.2% mortality in CABG with LVEF<20%; or some 500 arterial corrections in TGA without mortality, etc. Credibility problem! Massive number crunching from your institutional data base: this is not science, but only tabulation of results. Some significances might emerge by chance, with large number of variables. Still very common!
26
27 Vote about this abstract: Press 1: Accept Press 2 Reject Press 3 Possible
28 Perfect abstract: something new (TAVI), well documented multicentre study, good follow-up, important findings (difference in incidence of AV block). Accepted, with high score
29
30 Vote about this abstract: Press 1: Accept Press 2 Reject Press 3 Possible
31 Never introduce an abbreviation or acronym without explaining i it first time when used. Rejected: might be good work, but not for a clinically-oriented meeting like EACTS. MSC stands for mesenchymal y stem cell ; 5-aza stands for 5-aza-cytidine» Proper spelling is hyaluronic, not hyauronic
32
33 Vote about this abstract: Press 1: Accept Press 2 Reject Press 3 Possible
34 This is a very small group of patients for a 3 year period. How were they selected? Only a retrospective analysis: are both groups equivalent? Too many confounders (CABG, CTE). All patients receive a careful examination (pleonasm)! But still: ACCEPTED!
35
36 Vote about this abstract: Press 1: Accept Press 2 Reject Press 3 Possible
37 Excellent abstract, highest note at 2011 STS meeting in San Diego
38
39 Vote about this abstract: Press 1: Accept Press 2 Reject Press 3 Possible
40 Where are the actual values of echo measurements? We get only SD. Results do not support the conclusion. Authors state that the annulus is variable, but flexible devices should not be used? REJECTION
41
42 Vote about this abstract: Press 1: Accept Press 2 Reject Press 3 Possible
43 Very good abstract: a new method (ILR) with complete, long-term follow-up, and with important results. Accepted, with high grades
44
45 Vote about this abstract: Press 1: Accept Press 2 Reject Press 3 Possible
46 Standard surgical procedure since early sixties, very few patients. What is new?
47
48 Vote about this abstract: Press 1: Accept Press 2 Reject Press 3 Possible
49 Only two cases: what can be learned from these examples? There is even no data about outcome
50 RADIAL ARTERY GRAFTING: A TEN-YEAR PERSPECTIVE. (3.91) Objectives: To evaluate the results of the radial artery used as a second coronary graft to achieve arterial revascularization in a ten-year period. Methods: From August 1996 to December 2005 radial artery was employed as a coronary graft in 424 patients. The features of the patients were: Euroscore 4.0±3.1, expected mortality 4.8±1.1, mean age 68.9±8.4 years, left main disease 35.0%, unstable angina 66.6%, previous AMI 47.4% and mean ejection fraction 61.5±12.6%. Radial arteries were harvested as skeletonized grafts in all cases. A total of 543 anastomoses (48.2%) were constructed with 454 radial arteries. The mean of distal anastomoses per patient was 2.6±0.6, being 1.2±0.5 of radial artery. Therefore, the LIMA was used as a graft in 413 cases, the RIMA in 50, the right inferior epigastric artery in 16 and the saphenous vein in 101. OPCAB revascularization a a was performed in 56 cases (13.2%). Results: RESULTS. Exclusive arterial revascularization was achieved in 83.4% (354 patients). Hospital-in and/or 30 day-mortality was 3.7% (16 patients). There was 2.5% of perioperative AMI. No major complications were found related to radial artery harvesting. Thirty patients underwent radionuclide exercise test with tecnecium 22.4 months after the operation. Stress-induced defects were detected only in 2 cases (5%), which were reversible at rest in areas revascularizated with a radial artery graft. Conclusions: The radial artery is an excellent conduit for myocardial revascularization that provides very few local complications and should it be considered as a true alternative to the right internal mammary for arterial graft revascularization
51 Vote about this abstract: Press 1: Accept Press 2 Reject Press 3 Possible
52 Very mediocre abstract, only an institutional experience. Early mortality substantial. 48.2% of what? Calculations not correct (2/30 is 6.7% and not 5%). Very few late observations (7%). REJECTION RADIAL ARTERY GRAFTING: A TEN-YEAR PERSPECTIVE. (3.91) Objectives: To evaluate the results of the radial artery used as a second coronary graft to achieve arterial revascularization in a ten-year period. Methods: From August 1996 to December 2005 radial artery was employed as a coronary graft in 424 patients. The features of the patients were: Euroscore 4.0±3.1, expected mortality 4.8±1.1, mean age 68.9±8.4 years, left main disease 35.0%, unstable angina 66.6%, previous AMI 47.4% and mean ejection fraction 61.5±12.6%. Radial arteries were harvested as skeletonized grafts in all cases. A total of 543 anastomoses (48.2%) were constructed with 454 radial arteries. The mean of distal anastomoses per patient was 2.6±0.6, being 1.2±0.5 of radial artery. Therefore, the LIMA was used as a graft in 413 cases, the RIMA in 50, the right inferior epigastric artery in 16 and the saphenous vein in 101. OPCAB revascularization a a was performed in 56 cases (13.2%). Results: RESULTS. Exclusive arterial revascularization was achieved in 83.4% (354 patients). Hospital-in and/or 30 day-mortality was 3.7% (16 patients). There was 2.5% of perioperative AMI. No major complications were found related to radial artery harvesting. Thirty patients underwent radionuclide exercise test with tecnecium 22.4 months after the operation. Stress-induced defects were detected only in 2 cases (5%), which were reversible at rest in areas revascularizated with a radial artery graft. Conclusions: The radial artery is an excellent conduit for myocardial revascularization that provides very few local complications and should it be considered as a true alternative to the right internal mammary for arterial graft revascularization
53 NEUROPROTECTIVE STRATEGIES: A WAY TO IMPROVE NEUROLOGICAL OUTCOME IN CARDIAC SURGERY (3.83) Objectives: To evaluate the usefulness of some measures aimed to avoid brain injury during cardiac surgery. Methods: We analyzed 141 patients with high-risk of stroke (CAD and/or age 70 years) who underwent open cardiac surgery during Their features were: mean age years, previous neurological dysfunction 3.6%, extra cardiac arteriopathy 4.3%, diabetes mellitus 26.2% and hypertension 62.4%. Preoperative treatment with aspirin was present in 63% of patients. The following five steps were taken in a regular way: 1) Routine preoperative doppler scan of supraaortic trunks. 2) Arterial head with a centrifugal pump 3) Adequate systemic pressure during the CPB equal to the age of the patient. 4) Coated circuits. 5) Aprotinin in medium dose. We did not use epiaortic ultrasound. Of this population 67% underwent CABG, and 95% of their proximal anastomoses were performed on the aorta. Results: Following Roach s classification, there were no type I neurological complications, and 2 patients (1.2%) had type II outcomes (new seizures and encephalopathy). In-hospital mortality was 3.6% (5 patients), t none of them due to neurological l complications. The predicted d mortality according to logistic EuroSCORE was 5.7%. Conclusions: The low incidence of neurological complications suggests that our protective strategies were effective. Although many factors remain unclear, our results suggest that neurological deficit could be due to low cerebral blood flow rather than to atherosclerotic emboli. So, we strongly recommend putting these measures into practice. However, further prospective randomized clinical trials are warranted to prove new innovative concepts in clinical practice.
54 Vote about this abstract: Press 1: Accept Press 2 Reject Press 3 Possible
55 Very mediocre abstract. This is not a high-risk group! Lot of opinions without scientific proof. Conclusions not supported by the results. REJECTED NEUROPROTECTIVE STRATEGIES: A WAY TO IMPROVE NEUROLOGICAL OUTCOME IN CARDIAC SURGERY (3.83) Objectives: To evaluate the usefulness of some measures aimed to avoid brain injury during cardiac surgery. Methods: We analyzed 141 patients with high-risk of stroke (CAD and/or age 70 years) who underwent open cardiac surgery during Their features were: mean age years, previous neurological dysfunction 3.6%, extra cardiac arteriopathy 4.3%, diabetes mellitus 26.2% and hypertension 62.4%. Preoperative treatment with aspirin was present in 63% of patients. The following five steps were taken in a regular way: 1) Routine preoperative doppler scan of supraaortic trunks. 2) Arterial head with a centrifugal pump 3) Adequate systemic pressure during the CPB equal to the age of the patient. 4) Coated circuits. 5) Aprotinin in medium dose. We did not use epiaortic ultrasound. Of this population 67% underwent CABG, and 95% of their proximal anastomoses were performed on the aorta. Results: Following Roach s classification, there were no type I neurological complications, and 2 patients (1.2%) had type II outcomes (new seizures and encephalopathy). In-hospital mortality was 3.6% (5 patients), t none of them due to neurological l complications. The predicted d mortality according to logistic EuroSCORE was 5.7%. Conclusions: The low incidence of neurological complications suggests that our protective strategies were effective. Although many factors remain unclear, our results suggest that neurological deficit could be due to low cerebral blood flow rather than to atherosclerotic emboli. So, we strongly recommend putting these measures into practice. However, further prospective randomized clinical trials are warranted to prove new innovative concepts in clinical practice.
56 You stand the highest chance of getting your abstract accepted, when you have: Properly designed prospective randomized d study (admittedly, dl very difficult in our field). Apply accepted statistical methods (e.g. propensity score matching, metaanalysis) Present something new: technique, idea, experimental observation. Question an established belief or a presumed fact.
57 Evaluation of session Joint abstracts analysis in a moderated session Good exercise (Press 1) Somewhat useful (Press 2) Waste of time (Press 3)
Diagnostic, Technical and Medical
Diagnostic, Technical and Medical Approaches to Reduce CABG Related Stroke Pieter Kappetein, Michael Mack, M.D. Dept Thoracic Surgery, Rotterdam, The Netherlands Baylor Healthcare System Dallas, TX Background
More informationImportance of the third arterial graft in multiple arterial grafting strategies
Research Highlight Importance of the third arterial graft in multiple arterial grafting strategies David Glineur Department of Cardiovascular Surgery, Cliniques St Luc, Bouge and the Department of Cardiovascular
More informationTSDA ACGME Milestones
TSDA ACGME Milestones Short MW and Edwards JA. Assessing resident milestones using a CASPE March 2012 Short MW and Edwards JA. Assessing resident milestones using a CASPE March 2012 Short
More informationOn-Pump vs. Off-Pump CABG: The Controversy Continues. Miguel Sousa Uva Immediate Past President European Association for Cardiothoracic Surgery
On-Pump vs. Off-Pump CABG: The Controversy Continues Miguel Sousa Uva Immediate Past President European Association for Cardiothoracic Surgery On-pump vs. Off-Pump CABG: The Controversy Continues Conflict
More informationEACTS Adult Cardiac Database
EACTS Adult Cardiac Database Quality Improvement Programme List of changes to Version 2.0, 13 th Dec 2018, compared to version 1.0, 1 st May 2014. INTRODUCTORY NOTES This document s purpose is to list
More informationParis, August 28 th Gian Paolo Ussia on behalf of the CoreValve Italian Registry Investigators
Paris, August 28 th 2011 Is TAVI the definitive treatment in high risk patients? Impact Of Coronary Artery Disease In Elderly Patients Undergoing TAVI: Insight The Italian CoreValve Registry Gian Paolo
More informationSUPPLEMENTAL MATERIAL
SUPPLEMENTAL MATERIAL Table S1: Number and percentage of patients by age category Distribution of age Age
More informationNon-Selective Carotid Artery Ultrasound Screening in Patients Undergoing Coronary Artery Bypass Grafting: Is It Necessary?
Non-Selective Carotid Artery Ultrasound Screening in Patients Undergoing Coronary Artery Bypass Grafting: Is It Necessary? Khalil Masabni, Joseph F. Sabik III, Sajjad Raza, Theresa Carnes, Hemantha Koduri,
More informationDeclaration of conflict of interest NONE
Declaration of conflict of interest NONE Claudio Muneretto MD, PhD Director of Division of Cardiac Surgery University of Brescia Medical School Italy Hybrid Chymera Different features and potential advantages
More informationCost-effectiveness of minimally invasive coronary artery bypass surgery Arom K V, Emery R W, Flavin T F, Petersen R J
Cost-effectiveness of minimally invasive coronary artery bypass surgery Arom K V, Emery R W, Flavin T F, Petersen R J Record Status This is a critical abstract of an economic evaluation that meets the
More informationIntraoperative application of Cytosorb in cardiac surgery
Intraoperative application of Cytosorb in cardiac surgery Dr. Carolyn Weber Heart Center of the University of Cologne Dept. of Cardiothoracic Surgery Cologne, Germany SIRS & Cardiopulmonary Bypass (CPB)
More informationSURGICAL MYOCARDIAL REVASCULARIZATION: ARTERIAL VS VENOUS GRAFTS, SINGLE VS MULTIPLE GRAFTS?
SURGICAL MYOCARDIAL REVASCULARIZATION: ARTERIAL VS VENOUS GRAFTS, SINGLE VS MULTIPLE GRAFTS? Luigi Martinelli Chief, Dept. of Surgery Istituto Clinico Ligure di Alta Specialità RAPALLO During 1987 2006,
More informationCORONARY ARTERY BYPASS GRAFT (CABG) MEASURES GROUP OVERVIEW
CONARY ARTERY BYPASS GRAFT (CABG) MEASURES GROUP OVERVIEW 2015 PQRS OPTIONS F MEASURES GROUPS: 2015 PQRS MEASURES IN CONARY ARTERY BYPASS GRAFT (CABG) MEASURES GROUP: #43 Coronary Artery Bypass Graft (CABG):
More informationOPCABG for Full Myocardial Revascularisation How we do it
OPCABG for Full Myocardial Revascularisation How we do it 28 th SHA Conferance Dr.Farouk Oueida Head of Cardiac Surgery Dept. SBCC-Dammam KSA The Less Invasive CABG Full Revascularisation Full Sternotomy
More informationDisclosures The PREVENT IV Trial was supported by Corgentech and Bristol-Myers Squibb
Saphenous Vein Grafts with Multiple Versus Single Distal Targets in Patients Undergoing Coronary Artery Bypass Surgery: One-Year Graft Failure and Five-Year Outcomes from the Project of Ex-vivo Vein Graft
More informationNavigating the Dichotomies Between Literature and Your Clinical Practice
Navigating the Dichotomies Between Literature and Your Clinical Practice Robert Groom, CCP, FPP Cardiovascular Institute at Maine Medical Center Disclosures No relevant conflicts related to this presentation
More informationThe Ins and Outs of Cardiac Surgery. Stephanie Wold RN MN NP
The Ins and Outs of Cardiac Surgery Stephanie Wold RN MN NP 1 The Ins and Outs of Cardiac Surgery Cardiac Surgery in a Nutshell 2 Outline Wait Times and Referral Process for Cardiac Surgery Getting Ready
More informationISAR-LEFT MAIN: A Randomized Clinical Trial on Drug-Eluting Stents for Unprotected Left Main Lesions
Julinda Mehilli, MD Deutsches Herzzentrum Technische Universität Munich Germany ISAR-LEFT MAIN: A Randomized Clinical Trial on Drug-Eluting Stents for Unprotected Left Main Lesions Background Left main
More informationOPCAB IS NOT BETTER THAN CONVENTIONAL CABG
OPCAB IS NOT BETTER THAN CONVENTIONAL CABG Harold L. Lazar, M.D. Harold L. Lazar, M.D. Professor of Cardiothoracic Surgery Boston Medical Center and the Boston University School of Medicine Boston, MA
More informationQuality ID #166 (NQF 0131): Coronary Artery Bypass Graft (CABG): Stroke- National Quality Strategy Domain: Effective Clinical Care
Quality ID #166 (NQF 0131): Coronary Artery Bypass Graft (CABG): Stroke- National Quality Strategy Domain: Effective Clinical Care 2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY MEASURE TYPE: Outcome
More informationRevascularization after Drug-Eluting Stent Implantation or Coronary Artery Bypass Surgery for Multivessel Coronary Disease
Impact of Angiographic Complete Revascularization after Drug-Eluting Stent Implantation or Coronary Artery Bypass Surgery for Multivessel Coronary Disease Young-Hak Kim, Duk-Woo Park, Jong-Young Lee, Won-Jang
More informationMinimally invasive direct coronary artery bypass for left anterior descending artery revascularization analysis of 300 cases
Original paper Videosurgery Minimally invasive direct coronary artery bypass for left anterior descending artery revascularization analysis of 300 cases Lufeng Zhang, Zhongqi Cui, Zhiming Song, Hang Yang,
More informationSetting The setting was a hospital. The economic study was carried out in Australia.
Coronary artery bypass grafting (CABG) after initially successful percutaneous transluminal coronary angioplasty (PTCA): a review of 17 years experience Barakate M S, Hemli J M, Hughes C F, Bannon P G,
More informationESC Congress 2011 SIMULTANEOUS HYBRID REVASCULARIZATION OF CAROTID AND CORONARY DISEASE INITIAL RESULTS OF A NEW THERAPEUTIC APPROACH
ESC Congress 2011 SIMULTANEOUS HYBRID REVASCULARIZATION OF CAROTID AND CORONARY DISEASE IN PATIENTS WITH ACUTE CORONARY SYNDROME: INITIAL RESULTS OF A NEW THERAPEUTIC APPROACH AUTHORS: Marta Ponte 1, RICARDO
More informationThe Influence of Previous Percutaneous Coronary Intervention in Patients Undergoing Off-Pump Coronary Artery Bypass Grafting
Original Article The Influence of Previous Percutaneous Coronary Intervention in Patients Undergoing Off-Pump Coronary Artery Bypass Grafting Toshihiro Fukui, MD, Susumu Manabe, MD, Tomoki Shimokawa, MD,
More informationHidden coronary disease in carotid patients
6 th ACST-2 Collaborators Meeting in Valencia, Spain 24th and 25th September 2018 Hidden coronary disease in carotid patients Valerio Tolva Policlinico di Monza Italy Are we always aware of coronary anatomy?
More information2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process
Quality ID #44 (NQF 0236): Coronary Artery Bypass Graft (CABG): Preoperative Beta-Blocker in Patients with Isolated CABG Surgery National Quality Strategy Domain: Effective Clinical Care 2018 OPTIONS FOR
More informationLong-term graft patency after CABG: effects of distal anastomosis angle
Long-term graft patency after CABG: effects of distal anastomosis angle Grigore Tinica 1,2, Raluca Chistol 1, Mihail Enache 1,2, Cristina Furnica 2 1 Cardiovascular Institute, Iasi, Romania 2 Gr. T. Popa
More informationChoice of Hemodynamic Support During Coronary Artery Bypass Surgery for Prevention of Stroke
The Journal of The American Society of Extra-Corporeal Technology Choice of Hemodynamic Support During Coronary Artery Bypass Surgery for Prevention of Stroke Yasuyuki Shimada, MD, PhD;* Hitoshi Yaku,
More informationCOAGULATION, BLEEDING, AND TRANSFUSION IN URGENT AND EMERGENCY CORONARY SURGERY
COAGULATION, BLEEDING, AND TRANSFUSION IN URGENT AND EMERGENCY CORONARY SURGERY VALTER CASATI, M.D. DIVISION OF CARDIOVASCULAR ANESTHESIA AND INTENSIVE CARE CLINICA S. GAUDENZIO NOVARA (ITALY) ANTIPLATELET
More informationIncremental Value of Multiple Arterial conduits in CABG
Incremental Value of Multiple Arterial conduits in CABG Nirav C Patel MD FRCS CTh Professor Zucker School of Medicine at Hofstra Northwell Director of Robotic Cardiac Surgery Northwell Health Vice Chairman
More informationUnprotected LM intervention
Unprotected LM intervention Guideline for COMBAT Seung-Jung Park, MD, PhD Professor of Internal Medicine, Seoul, Korea Current Recommendation for unprotected LMCA Stenosis Class IIb C in ESC guideline
More informationSurgical vs. Percutaneous Revascularization in Patients with Diabetes and Acute Coronary Syndrome
Surgical vs. Percutaneous Revascularization in Patients with Diabetes and Acute Coronary Syndrome Chris C. Cook, MD Associate Professor of Surgery Director, CT Residency Program, WVU ACOI 10/17/18 No Disclosures
More informationAbout OMICS International Conferences
About OMICS Group OMICS Group is an amalgamation of Open Access publications and worldwide international science conferences and events. Established in the year 2007 with the sole aim of making the information
More informationCORONARY ARTERY BYPASS GRAFTING (CABG) (Part 1) Mark Shikhman, MD, Ph.D., CSA Andrea Scott, CST
CORONARY ARTERY BYPASS GRAFTING (CABG) (Part 1) Mark Shikhman, MD, Ph.D., CSA Andrea Scott, CST I have constructed this lecture based on publications by leading cardiothoracic American surgeons: Timothy
More information'Coronary artery bypass grafting in patients with acute coronary syndromes: perioperative strategies to improve outcome'
'Coronary artery bypass grafting in patients with acute coronary syndromes: perioperative strategies to improve outcome' Miguel Sousa Uva Chair ESC Cardiovascular Surgery WG Hospital da Cruz Vermelha Portuguesa
More informationAlfa Ferry FRCS Cardiac Surgeon OPERATIVE MANAGEMENT IN CORONARY ARTERY DISEASE
Alfa Ferry FRCS Cardiac Surgeon OPERATIVE MANAGEMENT IN CORONARY ARTERY DISEASE Management in CHD Medical (medikamentosa) Intervensi 1. Percutaneous ( PTCA & stenting ) 2. Surgical ( CABG, CABG & mitral
More informationDESCRIPTION: Percentage of patients aged 18 years and older undergoing isolated CABG surgery who received an IMA graft
Measure #43 (NQF 0134): Coronary Artery Bypass Graft (CABG): Use of Internal Mammary Artery (IMA) in Patients with Isolated CABG Surgery National Quality Strategy Domain: Effective Clinical Care 2017 OPTIONS
More informationSotirios N. Prapas, M.D., Ph.D, F.E.C.T.S.
CORONARY ARTERY REVASCULARIZATION WITH MILD AORTIC STENOSIS: STRATEGIES OF TREATMENT 9 th ANNUAL MEETING OF THE EAB SOCIETY, Pravets, Bulgaria, 2012 Sotirios N. Prapas, M.D., Ph.D, F.E.C.T.S. Director
More informationMandatory knowledge about natural history of coronary grafts. P.Sergeant P. Maureira K.U.Leuven, Belgium
Mandatory knowledge about natural history of coronary grafts P.Sergeant P. Maureira K.U.Leuven, Belgium Types of grafts Arterial ITA/IMA (internal thoracic/mammary artery) Radial artery Gastro-epiploïc
More informationBicuspid aortic root spared during ascending aorta surgery: an update of long-term results
Short Communication Bicuspid aortic root spared during ascending aorta surgery: an update of long-term results Marco Russo, Guglielmo Saitto, Paolo Nardi, Fabio Bertoldo, Carlo Bassano, Antonio Scafuri,
More informationFaculty/Presenter Disclosure
Faculty/Presenter Disclosure Faculty: Andre Lamy Relationships with commercial interests: Grants/Research Support: None Speakers Bureau/Honoraria: None Consulting Fees: None Other: None CORONARY: The Coronary
More informationThe MAIN-COMPARE Study
Long-Term Outcomes of Coronary Stent Implantation versus Bypass Surgery for the Treatment of Unprotected Left Main Coronary Artery Disease Revascularization for Unprotected Left MAIN Coronary Artery Stenosis:
More informationCONTEMPORARY USE OF ARTERIAL GRAFTS DURING CORONARY ARTERY BYPASS SURGERY: PARADIGM SHIFT? OR A LITTLE (MORE) TALK THAT NEEDS A LOT MORE ACTION
CONTEMPORARY USE OF ARTERIAL GRAFTS DURING CORONARY ARTERY BYPASS SURGERY: PARADIGM SHIFT? OR A LITTLE (MORE) TALK THAT NEEDS A LOT MORE ACTION JAMES L ZELLNER MD I have no financial disclosures. 1897
More informationORIGINAL ARTICLE. Peripheral Vascular Disease and Outcomes Following Coronary Artery Bypass Graft Surgery
ORIGINAL ARTICLE Peripheral Vascular Disease and Outcomes Following Coronary Artery Bypass Graft Surgery Ted Collison, MD; J. Michael Smith, MD; Amy M. Engel, MA Hypothesis: There is an increased operative
More informationSurgery for patients with diffuse atherosclerotic disease
Surgery for patients with diffuse atherosclerotic disease Special hospital for surgery Skopje Macedonia September, 2012 Mitrev Z, Anguseva T, E.Stoicovski, Hristov N, E.Idoski Oktomvri, 2008 Atherosclerosis
More information2017 Cardiology Survival Guide
2017 Cardiology Survival Guide Chapter 4: Cardiac Catheterization/Percutaneous Coronary Intervention A cardiac catheterization involves a physician inserting a thin plastic tube (catheter) into an artery
More informationSafety of Single- Versus Multi-vessel Angioplasty for Patients with AMI and Multi-vessel CAD
Safety of Single- Versus Multi-vessel Angioplasty for Patients with AMI and Multi-vessel CAD Mun K. Hong, MD Associate Professor of Medicine Director, Cardiovascular Intervention and Research Weill Cornell
More informationHeart may be rotated but not compressed
Tips And Techniques For Multivessel OPCAB John D. Puskas, MD, Emory University, Atlanta AATS Adult Cardiac Skills April 28, 2012 San Francisco, CA Beating Heart Surgery vs Beat The Heart Surgery OPCAB
More informationThe Second Best Arterial Graft:
The Second Best Arterial Graft: A Propensity Analysis of the Radial Artery Versus the Right Internal Thoracic Artery to Bypass the Circumflex Coronary Artery American Association for Thoracic Surgery,
More informationCoronary Artery Bypass Graft: Monitoring Patients and Detecting Complications
Coronary Artery Bypass Graft: Monitoring Patients and Detecting Complications Madhav Swaminathan, MD, FASE Professor of Anesthesiology Division of Cardiothoracic Anesthesia & Critical Care Duke University
More informationCase Report Left Main Stenosis. Percutaneous Coronary Intervention (PCI) or Coronary Artery Bypass Graft Surgery (CABG)?
Cronicon OPEN ACCESS CARDIOLOGY Case Report Left Main Stenosis. Percutaneous Coronary Intervention (PCI) or Coronary Artery Bypass Graft Surgery (CABG)? Valentin Hristov* Department of Cardiology, Specialized
More informationUseful? Definition of High-risk? Pre-OP/Intra-OP/Post-OP? Complication vs Benefit? Mortality? Morbidity?
Preoperative intraaortic balloon counterpulsation in high-risk CABG Stefan Klotz, M.D. Preoperative IABP in high-risk CABG Questions?? Useful? Definition of High-risk? Pre-OP/Intra-OP/Post-OP? Complication
More informationMyocardial enzyme release after standard coronary artery bypass grafting
Cardiopulmonary Support and Physiology Schachner et al Myocardial enzyme release in totally endoscopic coronary artery bypass grafting on the arrested heart Thomas Schachner, MD, a Nikolaos Bonaros, MD,
More informationThe most important advantage of CABG over PTCA is its
Coronary Artery Bypass With Only In Situ Bilateral Internal Thoracic Arteries and Right Gastroepiploic Artery Hiroshi Nishida, MD; Yasuko Tomizawa, MD; Masahiro Endo, MD; Hitoshi Koyanagi, MD; Hiroshi
More informationWIEF-AFF ROUNDTABLE Tokyo, Japan 26 May 2015
WIEF-AFF ROUNDTABLE 2015 Tokyo, Japan 26 May 2015 Regenerative Medicine Goal: - To restore organ +/- tissue function - For pts with serious injuries or chronic disease where the body unable to heal & restore
More informationPostoperative stroke after off-pump versus on-pump coronary artery bypass surgery
Postoperative stroke after off-pump versus on-pump coronary artery bypass surgery Fausto Biancari, MD, PhD, Martti Mosorin, MD, Elsi Rasinaho, MS, Jarmo Lahtinen, MD, Jouni Heikkinen, MD, Eija Niemelä,
More informationIntraoperative Surgical Guidance and Quality Assessment
Intraoperative Surgical Guidance and Quality Assessment For best surgical outcomes Improve surgical outcomes, demonstrate quality, and increase cost efficiency. The Medistim MiraQ Cardiac combines ultrasound
More informationAccepted Manuscript. Radial artery and bilateral mammary arteries in CABG: how much is too much? Derrick Y. Tam, MD, Stephen E.
Accepted Manuscript Radial artery and bilateral mammary arteries in CABG: how much is too much? Derrick Y. Tam, MD, Stephen E. Fremes, MD, MSc PII: S0022-5223(19)30032-7 DOI: https://doi.org/10.1016/j.jtcvs.2019.01.009
More informationReoperative Coronary Artery Bypass Grafting: Analysis of Early And Late Outcomes
Original Article Reoperative Coronary Artery Bypass Grafting: Analysis of Early And Late Outcomes AR Jodati, MA Yousefnia From Department of Cardiothoracic Surgery, Madani Heart Hospital, Tabriz University
More informationLeft Subclavian Artery Stenosis in Coronary Artery Bypass: Prevalence and Revascularization Strategies
Left Subclavian Artery Stenosis in Coronary Artery Bypass: Prevalence and Revascularization Strategies Ho Young Hwang, MD, Jin Hyun Kim, MD, Whal Lee, MD, PhD, Jae Hyung Park, MD, PhD, and Ki-Bong Kim,
More informationCABG Surgery following STEMI
CABG Surgery following STEMI Susana Harrington, MS,APRN-NP Cardio-Thoracic Surgery Nebraska Methodist Hospital February 15, 2018 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction:
More informationCoronary Artery Bypass Grafting in Diabetics: All Arterial or Hybrid?
Coronary Artery Bypass Grafting in Diabetics: All Arterial or Hybrid? Dr. Daniel Navia M.D. Chief Cardiac Surgery Department ICBA, Buenos Aires Argentina, 2018 No disclosures 2 Current evidence The FREEDOM
More informationGRAND ROUNDS - DILEMMAS IN ANTICOAGULATION AND ANTIPLATELET THERAPY. Nick Collins February 2017
GRAND ROUNDS - DILEMMAS IN ANTICOAGULATION AND ANTIPLATELET THERAPY Nick Collins February 2017 DISCLOSURES Before I commence Acknowledge.. Interventional Cardiologist Perception evolved. Interventional
More informationCurrent outcomes of off-pump coronary artery bypass grafting: evidence from real world practice
Review Article Current outcomes of off-pump coronary artery bypass grafting: evidence from real world practice Piroze M. Davierwala Department of Cardiac Surgery, Heart Center, University of Leipzig, Leipzig,
More informationThank you, chairpersons. Ladies and gentlemen, it is a great honor to have this opportunity to report and discuss the current status of off-pump CABG
Thank you, chairpersons. Ladies and gentlemen, it is a great honor to have this opportunity to report and discuss the current status of off-pump CABG in Japan. And again. I would like to thank Dr Puskas
More informationManaging Hypertension in the Perioperative Arena
Managing Hypertension in the Perioperative Arena Optimizing Perioperative Management Strategies for Hypertension in the Cardiac Surgical Patient Objectives: Treatment of hypertensive emergencies. ALBERT
More informationEfficacy and Safety of a Dual Ticagrelor plus Aspirin Antiplatelet Strategy after Coronary Artery Bypass Grafting: The DACAB Randomized Clinical Trial
Efficacy and Safety of a Dual Ticagrelor plus Aspirin Antiplatelet Strategy after Coronary Artery Bypass Grafting: The DACAB Randomized Clinical Trial Qiang Zhao 1 Yunpeng Zhu 1, Zhiyun u 2, Zhaoyun Cheng
More informationSteph ani eph ani Mi M ck i MD Cleveland Clinic
Stephanie Mick MD Stephanie Mick MD Cleveland Clinic Upper hemisternotomy AVR Ascending Aorta MVr Thoracotomy Based Anterior AVR Lateral Thoracotomy Mitral/Tricuspid surgery Robotically assisted surgery
More informationImproved long-term survival has been demonstrated by
Benefit of Bilateral Over Single Internal Mammary Artery Grafts for Multiple Coronary Artery Bypass Grafting Masahiro Endo, MD; Hiroshi Nishida, MD; Yasuko Tomizawa, MD; Hiroshi Kasanuki, MD Background
More informationImplications of the New ESC/EACTS Guidelines for Myocardial Revascularization in 2011
Implications of the New ESC/EACTS Guidelines for Myocardial Revascularization in 2011 Prof. Dr. Volkmar Falk Klinik für Herz- und Gefäßchirurgie, Universitätsspital Zürich, Schweiz In 2004 headlines were
More informationSupplementary Table S1: Proportion of missing values presents in the original dataset
Supplementary Table S1: Proportion of missing values presents in the original dataset Variable Included (%) Missing (%) Age 89067 (100.0) 0 (0.0) Gender 89067 (100.0) 0 (0.0) Smoking status 80706 (90.6)
More informationAtrial Fibrillation Predicts Worse Long Time Prognosis after CABG A 6-Year Survival Analysis
Open Journal of Thoracic Surgery, 2012, 2, 18-22 http://dx.doi.org/10.4236/ojts.2012.22006 Published Online June 2012 (http://www.scirp.org/journal/ojts) Atrial Fibrillation Predicts Worse Long Time Prognosis
More informationOccurrence of Bleeding and Thrombosis during Antiplatelet therapy In Non-cardiac surgery. A prospective observational study.
Occurrence of Bleeding and Thrombosis during Antiplatelet therapy In Non-cardiac surgery A prospective observational study OBTAIN Study Statistical Analysis Plan of Final Analysis Final Version: V1.1 from
More informationDuring the last years, many reports have clearly
Single Versus Bilateral Internal Mammary Artery for Isolated First Myocardial Revascularization in Multivessel Disease: Long-Term Clinical Results in Medically Treated Diabetic Patients Antonio Maria Calafiore,
More informationDaryoush Samim, Enrico Ferrari, MD, FETCS, PD&MER
On- pump versus off- pump coronary artery bypass grafting with left internal mammary artery for left anterior descending artery stenosis: a retrospective study over 15 years Daryoush Samim, Enrico Ferrari,
More informationMyocardial revascularization without cardiopulmonary
Multiple Arterial Conduits Without Cardiopulmonary Bypass: Early Angiographic Results Antonio M. Calafiore, MD, Giovanni Teodori, MD, Gabriele Di Giammarco, MD, Giuseppe Vitolla, MD, Nicola Maddestra,
More informationHow to manage the left subclavian and left vertebral artery during TEVAR
How to manage the left subclavian and left vertebral artery during TEVAR Jürg Schmidli Chief of Vascular Surgery Inselspital Hamburg 2017 Dept Cardiovascular Surgery, Bern, Switzerland Disclosure No Disclosures
More information2016 Physician Quality Reporting System Data Collection Form: Coronary Artery Bypass Graft (CABG) (for patients aged 18 years and older)
2016 Physician Quality Reporting System Data Collection Form: Coronary Artery Bypass Graft (CABG) (for patients aged 18 years and older) IMPORTANT: Any measure with a 0% performance rate (100% for inverse
More informationOff-Pump Cardiac Surgery is not Dead
Off-Pump Cardiac Surgery is not Dead Gonzalo J. Carrizo, M.D. Fellow Cardiothoracic Surgery Division Cardiothoracic Surgery Department of Surgery University of Colorado Hopeman Lectureship September 10,2007
More informationIschemic Heart Disease Interventional Treatment
Ischemic Heart Disease Interventional Treatment Cardiac Catheterization Laboratory Procedures (N = 89) is a regional and national referral center for percutaneous coronary intervention (PCI). A total of
More informationImproving the Quality of Coronary Bypass Surgery With Intraoperative Angiography Validation of a New Technique
Journal of the American College of Cardiology Vol. 46, No. 8, 2005 2005 by the American College of Cardiology Foundation ISSN 0735-1097/05/$30.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2005.05.081
More informationPerioperative Cardiology Consultations for Noncardiac Surgery Ischemic Heart Disease
2012 대한춘계심장학회 Perioperative Cardiology Consultations for Noncardiac Surgery Ischemic Heart Disease 울산의대울산대학병원심장내과이상곤 ECG CLASS IIb 1. Preoperative resting 12-lead ECG may be reasonable in patients with
More informationSTENTYS for Le, Main Sten2ng. Carlo Briguori, MD, PhD Clinica Mediterranea Naples, Italy
STENTYS for Le, Main Sten2ng Carlo Briguori, MD, PhD Clinica Mediterranea Naples, Italy Disclosure Statement of Financial Interest I, Carlo Briguori DO NOT have a financial interest/ arrangement or affilia2on
More informationCardiac evaluation for the noncardiac. Nathaen Weitzel MD University of Colorado Denver Dept of Anesthesiology
Cardiac evaluation for the noncardiac patient Nathaen Weitzel MD University of Colorado Denver Dept of Anesthesiology Objectives! Review ACC / AHA guidelines as updated for 2009! Discuss new recommendations
More informationLe# main treatment with Stentys stent. Carlo Briguori, MD, PhD Clinica Mediterranea Naples, Italy
Le# main treatment with Stentys stent Carlo Briguori, MD, PhD Clinica Mediterranea Naples, Italy Disclosure Statement of Financial Interest I, Carlo Briguori DO NOT have a financial interest/ arrangement
More informationSurgical AVR: Are there any contraindications? Pyowon Park Samsung Medical Center Seoul, Korea
Surgical AVR: Are there any contraindications? Pyowon Park Samsung Medical Center Seoul, Korea Contents Decision making in surgical AVR in old age Clinical results of AVR with tissue valve Impact of 19mm
More informationPreoperative Cardiac Risk Assessment: Approach & Guidelines
Preoperative Cardiac Risk Assessment: Approach & Guidelines By, Liam Morris, MD., FACC (02/03/18) CPG : Clinical Practice Guidelines GDMT : Guidelines Directed Medical Therapy GWC : Guideline Writing Committee
More informationWhen Should We Consider TAVI. (Surgeon s Viewpoint)? Pyowon Park Samsung Medical Center Seoul, Korea
When Should We Consider TAVI Procedure in Korea (Surgeon s Viewpoint)? Pyowon Park Samsung Medical Center Seoul, Korea Aortic Stenosis in Korea Rapidly increasing valve disease in Korea Still low incidence
More informationSaphenous Vein Autograft Replacement
Saphenous Vein Autograft Replacement of Severe Segmental Coronary Artery Occlusion Operative Technique Rene G. Favaloro, M.D. D irect operation on the coronary artery has been performed in 180 patients
More informationDistribution Of Grafts In Aortocoronary Bypass Surgery: Cardiovascular Surgery Fellowship Experience.
ISPUB.COM The Internet Journal of Thoracic and Cardiovascular Surgery Volume 17 Number 1 Distribution Of Grafts In Aortocoronary Bypass Surgery: Cardiovascular Surgery Fellowship Experience. J C Eze Citation
More informationThe clinical and prognostic benefits of coronary artery bypass grafting (CABG)
ORIGINAL ARTICLE Total arterial myocardial revascularization: analysis of initial experience Shahzad Gull Raja, MRCS; Zulfiqar Haider, FRCS; Haider Zaman, FRCS (CTh); Mukhtar Ahmed, FRCS BACKGROUND: Total
More informationTHE NATIONAL QUALITY FORUM
THE NATIONAL QUALITY FORUM National Voluntary Consensus Standards for Patient Outcomes Table of Measures Submitted-Phase 1 As of March 5, 2010 Note: This information is for personal and noncommercial use
More informationChapter 4 Section 9.1
Surgery Chapter 4 Section 9.1 Issue Date: August 26, 1985 Authority: 32 CFR 199.4(c)(2) and (c)(3) 1.0 CPT 1 PROCEDURE CODES 33010-33130, 33140, 33141, 33200-37186, 37195-37785, 92950-93272, 93303-93581,
More informationQuality Measures MIPS CV Specific
Quality Measures MIPS CV Specific MEASURE NAME Atrial Fibrillation and Atrial Flutter: Chronic Anticoagulation Therapy CAHPS for MIPS Clinician/Group Survey Cardiac Rehabilitation Patient Referral from
More informationTitle:Relation Between E/e' ratio and NT-proBNP Levels in Elderly Patients with Symptomatic Severe Aortic Stenosis
Author's response to reviews Title:Relation Between E/e' ratio and NT-proBNP Levels in Elderly Patients with Symptomatic Severe Aortic Stenosis Authors: Mihai Strachinaru (m.strachinaru@erasmusmc.nl) Bas
More informationWith Regards to Afflictions of the Heart, Are Men and Women Created Equal?
With Regards to Afflictions of the Heart, Are Men and Women Created Equal? Jennifer S. Lawton, M.D. Associate Professor of Surgery Washington University School of Medicine AATS/STS Adult Cardiac Surgery
More informationValve Disease in Patients With Heart Failure TAVI or Surgery? Miguel Sousa Uva Hospital Cruz Vermelha Lisbon, Portugal
Valve Disease in Patients With Heart Failure TAVI or Surgery? Miguel Sousa Uva Hospital Cruz Vermelha Lisbon, Portugal I have nothing to disclose. Wide Spectrum Stable vs Decompensated NYHA II IV? Ejection
More informationIs bypass surgery needed for elderly patients with LMT disease? From the surgical point of view
CCT 2003 (Kobe) Is bypass surgery needed for elderly patients with LMT disease? From the surgical point of view Hitoshi Yaku, MD, PhD Department of Cardiovascular Surgery Kyoto Prefectural University of
More informationConventional CABG Or On Pump Beating Heart: A Difference In Myocardial Injury?
Conventional CABG Or On Pump Beating Heart: A Difference In Myocardial Injury? Kornelis J. Koopmans Medical Center Leeuwarden Leeuwarden, The Netherlands I have no disclosures Disclosures Different techniques
More information